| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/04/1997 | EP0776197A1 Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives |
| 06/04/1997 | EP0776196A1 Hydrophilic controlled release device |
| 06/04/1997 | EP0776195A1 Drug delivery composition containing chitosan or derivative thereof having a defined z. potential |
| 06/04/1997 | EP0705085A4 Molecular transdermal transport system |
| 06/04/1997 | EP0697859B1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions |
| 06/04/1997 | EP0661924B1 Surface treatment composition |
| 06/04/1997 | EP0621784B1 An iron-containing composition for the prevention of anaemia and a method for producing the composition |
| 06/04/1997 | CN1151168A Method and compositions for the dry powder formulation of interferons |
| 06/04/1997 | CN1151115A Topical compositions comprising N-acetyl-L-cysteine |
| 06/04/1997 | CN1035038C Preparation of pharmaceutical composition for preventing venereal disease |
| 06/03/1997 | US5635609 Having stable membrane encapsulating particle core; cosmetics, drugs, reagents |
| 06/03/1997 | US5635606 Contacting sample with an oligosaccharide sequence covalently attached to biogenic inert, solid silicate support through a linker arm, separating support containg toxin a from sample; treats antibiotic related diarrhea |
| 06/03/1997 | US5635599 Circularly permuted il4, il2, granulocyte macrophage colony stimulating factor or granulocyte colony stimulating factor fused to a cytotoxin, i.e., pseudomonas exotoxin, diphtheria toxin without the native receptor-binding domain; cancer |
| 06/03/1997 | US5635571 Polymerizable macromonomers and polymers prepared therefrom |
| 06/03/1997 | US5635540 Stabilized topical pharmaceutical preparations |
| 06/03/1997 | US5635538 Fluorocarbon emulsions with reduced pulmonary gas-trapping properties |
| 06/03/1997 | US5635536 Emulsion suitable for administering a sphingolipid |
| 06/03/1997 | US5635520 Anti-ulcer compositions suitable for rectal administration |
| 06/03/1997 | US5635497 Topical application compositions |
| 06/03/1997 | US5635493 Methods and compositions for poly-β-1-4-N-acetylglucosamine chemotherapeutics |
| 06/03/1997 | US5635492 Aqueous mixture of microbiocide and rhamsan gum which has high retention efficiency |
| 06/03/1997 | US5635491 Incorporation of maltose controls particle size |
| 06/03/1997 | US5635405 Gold sols or dye particles surrounded by hydrophilic copolymers having functional groups which bind to immunologically active materials, for kits, dipsticks |
| 06/03/1997 | US5635385 Multi-unit ribozyme inhibition of oncogene gene expression |
| 06/03/1997 | US5635383 Delivering complex of polynucleotide and carrier comprising polycationic binding agent and ligand specific for cell receptor to cell wherein polynucleotide is released from carrier on entry into cell |
| 06/03/1997 | US5635382 Method for enhancing transmembrane transport of exogenous molecules |
| 06/03/1997 | US5635238 Provides fast release of active material when wetted, typically by bodily fluids as in cosmetic use |
| 06/03/1997 | US5635214 Sorbent precipitated silica particulates |
| 06/03/1997 | US5635213 Pharmaceutical formulation |
| 06/03/1997 | US5635207 Subjecting aqueous medium containing oxygen binding protein to high intensity ultrasound conditions to promote crosslinking and form polymeric shell of specified size |
| 06/03/1997 | US5635205 Carrier system including local anesthetic, amphipathic polar lipid, nonpolar lipid comprising mixture of glycerol monocaprylate and glycerol monocaprate, wherein discrete lipid particles form in aqueous medium |
| 06/03/1997 | US5635200 Having polymeric or cellulosic binder and lipid coating |
| 06/03/1997 | US5635187 Adding phytogenic compounds to storage solution to increase organ preservation for transplantation |
| 06/03/1997 | US5635186 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 06/03/1997 | US5635185 Extracts of Piliostigma thonningii, the use thereof and formulations containing them |
| 06/03/1997 | US5635180 Alteration of pharmacokinetics of proteins by charge modification |
| 06/03/1997 | US5635176 Pharmaceutical compositions containing IL-6 |
| 06/03/1997 | US5635172 Comprising a drug for controlling and treating ocular hypertension, an anionic mucomimetic polymer having carboxyl groups and a cation exchane resin |
| 06/03/1997 | US5635164 Stick composition with sodium chloride and stearyl alcohol |
| 06/03/1997 | US5635161 Pulmonary delivery |
| 06/03/1997 | US5635159 Aerosol drug formulations containing polyglycolyzed glycerides |
| 06/03/1997 | US5635156 Subjecting recipient to treatment with non-lethal dose of total body irradiation, alkylating agent, antibody or active fragment thereof, transplanting with donor cell preparation containing hematopoietic stem cells |
| 06/03/1997 | CA2090848C Stabilized peroxide gels containing fluoride |
| 05/29/1997 | WO1997019183A2 Tissue-specific transcription of dna sequence encoding a heterologous enzyme for use in prodrug therapy to lung cancer |
| 05/29/1997 | WO1997019180A2 Vector consisting of a transcriptional regulatory dna sequence linked to a dna sequence encoding beta-lactamase for enzyme prodrug therapy |
| 05/29/1997 | WO1997019108A1 Pulmonary surfactant peptide solubilization process |
| 05/29/1997 | WO1997019105A1 Multivalent polymers, processes for their preparation, and their use for preparing biologically active compounds. |
| 05/29/1997 | WO1997018840A2 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures |
| 05/29/1997 | WO1997018839A1 Solid mixtures of cyclodextrins prepared via melt-extrusion |
| 05/29/1997 | WO1997018835A1 Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 05/29/1997 | WO1997018829A1 Cartilage/bone inducing materials for reparation |
| 05/29/1997 | WO1997018816A2 Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications |
| 05/29/1997 | WO1997018814A1 Pharmaceutical formulations |
| 05/29/1997 | WO1997018790A2 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 05/29/1997 | WO1997015288A3 Method and preparations for stabilizing biological materials by drying methods without freezing |
| 05/29/1997 | CA2238429A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 05/29/1997 | CA2238262A1 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 05/29/1997 | CA2232715A1 Pharmaceutical formulations |
| 05/29/1997 | CA2232135A1 Solid mixtures of cyclodextrins prepared via melt-extrusion |
| 05/28/1997 | EP0775496A1 Cholesterol ester clathrate, water-holding composition, hydrous compositions, cosmetics containing the same, and processes for the preparation thereof |
| 05/28/1997 | EP0775495A1 Use of a disaccharide as stabilizer for liquid protein mixtures and liquid protein mixtures containing a disaccharide |
| 05/28/1997 | EP0775494A1 Peroral immunogen composition and process for producing the same |
| 05/28/1997 | EP0775485A1 New dosage form of hydroxocobalamin and its use in cyanide poisoning |
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775173A1 Starch-bound cellular matrix |
| 05/28/1997 | EP0775128A1 Preparation of immunogens and other conjugates of drugs |
| 05/28/1997 | EP0774976A1 Conjugates of vitamin b12 and proteins |
| 05/28/1997 | EP0774975A1 Use of starch for transdermal applications |
| 05/28/1997 | EP0774974A1 Novel vaccine adjuvant and vaccine |
| 05/28/1997 | EP0774964A1 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 05/28/1997 | EP0774958A1 Vesicle formulation |
| 05/28/1997 | EP0774956A1 PROCESS FOR PREPARING BECLOMETHASONE DIPROPIONATE FREON$m(3) CLATHRATE |
| 05/28/1997 | EP0774898A1 Methods of making sustained release biocidal compositions |
| 05/28/1997 | EP0674734B1 Ski slope maintenance device |
| 05/28/1997 | EP0594707B1 Preparations comprising a fluorocarbon and a lipophilic/fluorophilic organic compound, and their uses |
| 05/28/1997 | EP0546092B1 Therapeutic ribozyme compositions |
| 05/28/1997 | EP0407617B1 Process for the preparation of a biocompatible polyester |
| 05/28/1997 | CN1150761A Delivery of therapeutic agents to receptors using polysaccharides |
| 05/28/1997 | CN1150756A Stable protein: phospholipid composition and method |
| 05/27/1997 | US5633395 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/27/1997 | US5633368 Water solubility |
| 05/27/1997 | US5633351 Targeting protein-diagnostic/therapeutic agent conjugates having Schiff base linkages |
| 05/27/1997 | US5633260 11,7 Substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof |
| 05/27/1997 | US5633240 Parenteral solutions containing metolazone |
| 05/27/1997 | US5633226 Water in oil emulsion with water solubility active ingredient, triglyceride or diester of propylene glycol, surfactant and additive capable of converting mixture to oil in water emulsion by addition of water |
| 05/27/1997 | US5633028 Jagged, rough edges, surfactants |
| 05/27/1997 | US5633006 Oxide of a group 2a metal |
| 05/27/1997 | US5633005 Dimeticon pastilles |
| 05/27/1997 | US5633001 Composition and a method for tissue augmentation |
| 05/27/1997 | US5632991 Antibodies specific for E-selectin and the uses thereof |
| 05/27/1997 | US5632990 Linked to carboxypeptidase or nitroreductase; anticarcinogenic agents |
| 05/27/1997 | US5632981 Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 05/27/1997 | US5632970 Fluoresence detection using texaphyrins |
| 05/27/1997 | US5632727 Biodegradable film dressing and method for its formation |
| 05/27/1997 | CA2106215C Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress |
| 05/22/1997 | WO1997018320A1 Process for the preparation of materials with a high content of long chain polyunsaturated fatty acids |
| 05/22/1997 | WO1997018245A1 Complex of naproxen and beta-cyclodextrin |
| 05/22/1997 | WO1997018244A1 Photocured cross-linked-hyaluronic acid gel and method of preparation thereof |
| 05/22/1997 | WO1997018185A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 05/22/1997 | WO1997017993A1 Tumor associated internalizing antigens and methods for targeting therapeutic agents |